Stocks & ETFs

Philip Morris Unveils Positive Results on Clinical Study

Philip Morris Unveils Positive Results on Clinical Study

March 27, 2017 at 11:41 am 0 comments

Philip Morris International reported pre-market Monday positive results from a clinical study conducted in Japan on its first electronically heated tobacco product IQOS. The study showed that smokers who switched to the product reduced their exposure to 15 harmful chemicals to levels that approached those of individuals who quit smoking. The study also showed improvements in indicators specific to smoking-relatedRead More

La Jolla Pharmaceutical Prices Share Offering

La Jolla Pharmaceutical Prices Share Offering

March 23, 2017 at 11:46 am 0 comments

La Jolla Pharmaceutical Company said pre-market Thursday it priced its underwritten public offering of 3.7 million shares of common stock at $33.50 per share, equal to a 1.8% discount relative to the stock’s Wednesday closing price, for expected gross proceeds of $125 million. Shares were up 3.6% in recent pre-market trade. In addition, La Jolla granted the underwriters a 30-dayRead More

Novan Names William Hodges as Interim CFO

Novan Names William Hodges as Interim CFO

March 22, 2017 at 12:12 pm 0 comments

Novan said early Wednesday its board appointed William Hodges as interim CFO, effective immediately, following the departure of Richard Peterson, who is leaving to pursue other business interests. Hodges has a “long” career in public company finance positions, including most recently serving as CFO of Pozen, Inc., the company said in a statement. Furthermore, Paula Brown Stafford has been appointedRead More

Adaptimmune Therapeutics Names William Betrand as Chief Operating Officer

Adaptimmune Therapeutics Names William Betrand as Chief Operating Officer

March 15, 2017 at 12:02 pm 0 comments

Adaptimmune Therapeutics said Wednesday it has appointed William Betrand to the role of chief operating officer, effective immediately, succeeding Helen Tayton-Martin, who has been named chief business officer. Bertrand will assume responsibility for a range of operational functions, including compliance, risk management, human resources and legal/IP, based at Adaptimmune’s U.S. headquarters in Philadelphia. Tayton-Martin will now focus on optimizing theRead More

Halozyme Therapeutics Q4 Loss, Revenues Top Views

Halozyme Therapeutics Q4 Loss, Revenues Top Views

March 1, 2017 at 1:22 pm 0 comments

Halozyme Therapeutics (HALO), a biotechnology company developing cancer treatments, posted a narrower-than expected loss per share for Q4. The net loss was $0.21 per share, compared with earnings per share of $0.03 in the same quarter a year earlier. Analysts in a Capital IQ poll expected loss per share of $0.30 on average. Revenue in Q4 was $39.0 million comparedRead More

McDonald’s Rises 1% Off Halt After Co Unveils Global Growth Plan

McDonald’s Rises 1% Off Halt After Co Unveils Global Growth Plan

March 1, 2017 at 1:15 pm 0 comments

Shares of McDonald’s (MCD), which were halted earlier, climbed more than 1% after CEO Steve Easterbrook and members of the senior management team detailed the company’s long-term global growth plan at an investor day event in downtown Chicago. The company said in a statement on Wednesday its growth plan focuses on enhancing digital capabilities and the use of technology toRead More

Oil Prices Pare Early Gains Following Eighth Consecutive Week of Rising US Stockpiles

Oil Prices Pare Early Gains Following Eighth Consecutive Week of Rising US Stockpiles

March 1, 2017 at 11:28 am 0 comments

Oil prices were paring early gains on Wednesday after government data showed that US inventories of oil expanded last week, marking the eighth consecutive week in which stockpiles have increased. West Texas Intermediate (WTI) crude oil, the main US benchmark, was trading 0.01% lower at $53.98 per barrel recently while Brent crude, the international gauge, was 0.02% higher at $56.52Read More